Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurodegenerative Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02236286
What this trial is testing

Frontal Cortex and Gait Freezing in Parkinson's Disease: Rehabilitation Impact

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 16
Testing effectiveness (Phase 2)Study completedNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 99
Early research (Phase 1)Study completedNCT03562494
What this trial is testing

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Who this might be right for
Parkinson's Disease
Neurocrine Biosciences 14
Not applicableStudy completedNCT03673722
What this trial is testing

Mediterranean Diet, Exercise and Dementia Risk in UK Adults

Who this might be right for
Dementia
University of East Anglia 108
Not applicableEnded earlyNCT06140329
What this trial is testing

Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

Who this might be right for
Autosomal Dominant Optic AtrophyOptic Atrophy, Autosomal DominantOptic Atrophies, Hereditary+1 more
PYC Therapeutics 1
Testing effectiveness (Phase 2)Ended earlyNCT03306329
What this trial is testing

DNS-7801 vs. Placebo in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Dart NeuroScience, LLC 5
Large-scale testing (Phase 3)Study completedNCT00372879
What this trial is testing

Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 32
Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Not applicableStudy completedNCT03232996
What this trial is testing

Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease.

Who this might be right for
Parkinson DiseaseParkinson
University of Manitoba 30
Not applicableStudy completedNCT03221296
What this trial is testing

Fall Prevention - Vestibular Rehabilitation

Who this might be right for
Alzheimer Dementia (AD)Vascular Dementia
University Health Network, Toronto 29
Not applicableLooking for participantsNCT06965062
What this trial is testing

Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)

Who this might be right for
Alzheimer DiseaseDementia Alzheimer TypeDementia Alzheimer's Type+2 more
Vincent Tay Khwee Soon 10
Not applicableActive Not RecruitingNCT05388370
What this trial is testing

PASS of Paediatric Patients Initiating Selumetinib

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 124
Not applicableUnknownNCT01089270
What this trial is testing

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Who this might be right for
Parkinson Disease
Tel-Aviv Sourasky Medical Center 80
Not applicableStudy completedNCT05047705
What this trial is testing

Investigating Distress Tolerance in Adults With Tourette Syndrome

Who this might be right for
Tourette SyndromeTic DisordersTics
Johns Hopkins University 9
Not applicableStudy completedNCT06419322
What this trial is testing

Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).

Who this might be right for
Spinal Muscular Atrophy
University of Oxford 14
Large-scale testing (Phase 3)Ended earlyNCT01215227
What this trial is testing

An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
Merck Sharp & Dohme LLC 839
Not applicableStudy completedNCT02198586
What this trial is testing

Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old

Who this might be right for
Alzheimer's Disease
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation 575
Testing effectiveness (Phase 2)Active Not RecruitingNCT04491383
What this trial is testing

Tocotrienols in Parkinson's Disease (PD)

Who this might be right for
Neuro-Degenerative DiseaseParkinson Disease
National Neuroscience Institute 100
Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Very early researchStudy completedNCT00657202
What this trial is testing

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis Type 1Cutaneous Neurofibromas
Massachusetts General Hospital 11
Next Page